Effect of Vancomycin and Infliximab on clinical parameters and mucosal healing in children with Primary Sclerosing Cholangitis (PSC)- Ulcerative Colitis (UC) or moderate to severe UC
Not yet recruiting
- Conditions
- lcerative ColitisPrimary Sclerosing Cholangitis
- Registration Number
- ACTRN12617001146381
- Lead Sponsor
- Associate Professor Peter Lewindon
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not yet recruiting
- Sex
- All
- Target Recruitment
- 100
Inclusion Criteria
Not provided
Exclusion Criteria
Not provided
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method